Signature Resources Capital Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Signature Resources Capital Management, LLC
- $112 Billion
- Q4 2024
A detailed history of Signature Resources Capital Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Signature Resources Capital Management, LLC holds 15 shares of RARE stock, worth $660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$660
Previous $833,000
24.25%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$438 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$247 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$225 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$183 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$135 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.09B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...